Life Insurance Quotes

Alzheimer's drug market expected to triple over next 10 years

10/07/11

Decision Resources, a top research and advisory firm for healthcare and pharmaceutical issues, recently released findings that indicate the Alzheimer's disease drug market is expected to triple over the next 10 years.

The increase will bring the estimated market worth from $5.4 billion recorded in 2010 to $14.3 billion in 2020 for the U.S. and several other countries including France, Germany, Spain and the U.K.

"Thought leaders are cautiously optimistic that the anti-Ass MAbs will be able to slow the rate of neurodegeneration and consequently cognitive and functional decline - however, they await evidence from ongoing late-stage clinical trials," said Georgiana Kuhlmann, analyst at Decision Resources. "Assuming the MAbs are able to demonstrate such efficacy, they will have the greatest clinical and commercial promise among therapies included in our forecast for Alzheimer's disease."

Senior citizens suffering from Alzheimer's have benefited from a series of revelations concerning the disease. Researchers at the University of California Los Angeles recently unveiled new evidence that suggests women who undergo hysterectomies have increased levels of iron in their brain following the procedure, which can lead to a higher chance of developing Alzheimer's and related diseases.
 

Talk to an Advisor

A licensed insurance advisor can explain your options and help you choose the right life insurance for your needs.

Call: 1-800-823-4852

Chat: Live Advisor Chat

Sm

A few of the carriers we quote